King Charles health update: How long does cancer treatment last
EXCLUSIVE: An oncologist has revealed how long different cancer treatments can go on for, as the King revealed he will return to frontline duties for the first time since his diagnosis. (Source: Daily Express - Health)
Source: Daily Express - Health - April 26, 2024 Category: Consumer Health News Source Type: news
A timeline of King Charles' health struggles, from his cancer diagnosis to his return to public duties
None Buckingham Palace confirmed King Charles III was diagnosed with cancer in January. • None The announcement came after the British monarch sought treatment for an enlarged prostate. • None After months of stepping back, the palace announced Charles was returning to public duties in April. King…#nonebuckinghampalace #kingcharlesiii #charlesiii #buckinghampalace #katemiddleton #princewilliam #kensingtonpalace #princeharry #rishisunak #eastersunday (Source: Reuters: Health)
Source: Reuters: Health - April 26, 2024 Category: Consumer Health News Source Type: news
EMA Approves Factor VIII Deficiency Clotting Drug EMA Approves Factor VIII Deficiency Clotting Drug
European Union marketing authorization recommended for Altuvoct for hemophilia A caused by factor VIII deficiency.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 26, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
King Charles to Resume Royal Duties After Cancer Diagnosis
King Charles III is set to resume public appearances for the first time after his cancer diagnosis and current medical treatment. “His Majesty The King will shortly return to public-facing duties after a period of treatment and recuperation following his recent cancer diagnosis,” Buckingham Palace…#charlesiii #hismajestyking #buckinghampalace #palace #kingandqueen #empress #coronation #katemiddleton (Source: Reuters: Health)
Source: Reuters: Health - April 26, 2024 Category: Consumer Health News Source Type: news
Clue to Aspirin, Colon Cancer Link; New Lutathera Approval; AI & Electronic Records
(MedPage Today) -- Possibly uncovering a clue to a longstanding mystery, Italian researchers found that aspirin may help prevent colorectal cancer by pointing the immune system toward cancer cells. (Cancer)
The FDA expanded indications for lutetium... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 26, 2024 Category: Hematology Source Type: news
Conference MDAngle: AUA 2024 Metastatic Prostate Cancer Conference MDAngle: AUA 2024 Metastatic Prostate Cancer
Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 26, 2024 Category: Consumer Health News Tags: Hematology-Oncology MDAngle Source Type: news
AUA 2024: Awaiting New Data in Metastatic Prostate Cancer AUA 2024: Awaiting New Data in Metastatic Prostate Cancer
Dr Kelvin Moses previews some of the exciting trials and guideline updates being presented at AUA 2024.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 26, 2024 Category: Consumer Health News Tags: Hematology-Oncology MDAngle Source Type: news
Return to work will be 'therapeutic' for King Charles and getting back to 'normality' could speed up his cancer recovery, top expert Professor Karol Sikora claims
Buckingham Palace today announced the King would be returning to public-facing duties after a three-month absence. (Source: the Mail online | Health)
Source: the Mail online | Health - April 26, 2024 Category: Consumer Health News Source Type: news
King Charles' health history revealed, from his cancer battle and broken rib to his 'sausage fingers'
Buckingham Palace today revealed King Charles will return to public-facing duties. Here, MailOnline details Charles' known health issues over the years. (Source: the Mail online | Health)
Source: the Mail online | Health - April 26, 2024 Category: Consumer Health News Source Type: news
How is the King's cancer treatment going?
The King's medical team are "sufficiently pleased" with his progress after he was diagnosed with cancer in February. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 26, 2024 Category: Consumer Health News Source Type: news
Africa: Africa Steps Up the Fight as Non-Communicable Diseases Rise Sharply
[allAfrica] Non-communicable diseases, or NCDs, are a leading cause of death globally, with a disproportionate impact on low- and middle-income countries. NCDs are long-term conditions that are not transmitted from person to person. They can develop slowly over time or cause sudden death. According to WHO, the five main types are cardiovascular diseases (heart attacks and strokes), cancers, chronic respiratory diseases (like asthma), diabetes, and mental health conditions. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 26, 2024 Category: African Health Tags: Africa Health and Medicine Noncommunicable Diseases Source Type: news
Quadruplet Shows 'Excellent Activity' in Myeloma Patients Who Defer HSCT
(MedPage Today) -- Adding the CD38 monoclonal antibody isatuximab (Sarclisa) to a backbone of carfilzomib (Kyprolis), lenalidomide (Revlimid), and dexamethasone (KRd) induced deep and durable responses in a multiple myeloma study of untreated transplant... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 26, 2024 Category: Hematology Source Type: news
My common breastfeeding problem was actually stage 4 cancer - a week before giving birth I was given six months to live
Lindsey Parr Gritton of Georgia was 29 years old and 36 weeks pregnant with her second child when she was diagnosed with stage four breast cancer. Doctors first mistook it for mastitis. (Source: the Mail online | Health)
Source: the Mail online | Health - April 26, 2024 Category: Consumer Health News Source Type: news
CHMP recommends EU approval of Roche ’s Alecensa as the first adjuvant treatment for resected ALK-positive early-stage lung cancer
If approved, Alecensa will be the first and only ALK inhibitor approved for people with resected ALK-positive early-stage non-small cell lung cancer (NSCLC)The positive recommendation is based on results from the Phase III ALINA study where Alecensa showed an unprecedented 76% reduction in the risk of disease recurrence or death, compared to adjuvant chemotherapy1With about half of people living with early-stage NSCLC experiencing disease recurrence or death following surgery, Alecensa could minimise the risk by treating NSCLC before it has spread2Basel, 26 April 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today th...
Source: Roche Investor Update - April 26, 2024 Category: Pharmaceuticals Source Type: news
Europe Recommends Three Cancer Drugs Europe Recommends Three Cancer Drugs
The European Medicines Agency has recommended Fruzaqla, Truqap, and Eribulin Baxter for use in the treatment of specific colorectal and breast cancers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 26, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
